Involvement of serotonin 2A receptor activation in modulating medial prefrontal cortex and amygdala neuronal activation during novelty-exposure

•Ketanserin blocks novelty-induced neuronal activation in medial prefrontal cortex.•This is accompanied by decreased neuronal activation in the basolateral amygdala.•Ketanserin makes basolateral amygdala more reactive towards the anxiogenic stimulus.•5-HT2A blockade does not affect activation of str...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Behavioural brain research 2017-05, Vol.326, p.1-12
Hauptverfasser: Hervig, Mona El-Sayed, Jensen, Nadja Cecilie Hvid, Rasmussen, Nadja Bredo, Rydbirk, Rasmus, Olesen, Mikkel Vestergaard, Hay-Schmidt, Anders, Pakkenberg, Bente, Aznar, Susana
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 12
container_issue
container_start_page 1
container_title Behavioural brain research
container_volume 326
creator Hervig, Mona El-Sayed
Jensen, Nadja Cecilie Hvid
Rasmussen, Nadja Bredo
Rydbirk, Rasmus
Olesen, Mikkel Vestergaard
Hay-Schmidt, Anders
Pakkenberg, Bente
Aznar, Susana
description •Ketanserin blocks novelty-induced neuronal activation in medial prefrontal cortex.•This is accompanied by decreased neuronal activation in the basolateral amygdala.•Ketanserin makes basolateral amygdala more reactive towards the anxiogenic stimulus.•5-HT2A blockade does not affect activation of striatal projecting amygdala neurons. The medial prefrontal cortex (PFC) plays a major role in executive function by exerting a top-down control onto subcortical areas. Novelty-induced frontal cortex activation is 5-HT2A receptor (5-HT2AR) dependent. Here, we further investigated how blockade of 5-HT2ARs in mice exposed to a novel open-field arena affects medial PFC activation and basolateral amygdala (BLA) reactivity. We used c-Fos immunoreactivity (IR) as a marker of neuronal activation and stereological quantification for obtaining the total number of c-Fos-IR neurons as a measure of regional activation. We further examined the impact of 5-HT2AR blockade on the striatal-projecting BLA neurons. Systemic administration of ketanserin (0.5mg/kg) prior to novel open-field exposure resulted in reduced total numbers of c-Fos-IR cells in dorsomedial PFC areas and the BLA. Moreover, there was a positive correlation between the relative time spent in the centre of the open-field and BLA c-Fos-IR in the ketanserin-treated animals. Unilateral medial PFC lesions blocked this effect, ascertaining an involvement of this frontal cortex area. On the other hand, medial PFC lesioning exacerbated the more anxiogenic-like behaviour of the ketanserin-treated animals, upholding its involvement in modulating averseness. Ketanserin did not affect the number of activated striatal-projecting BLA neurons (measured by number of Cholera Toxin b (CTb) retrograde labelled neurons also being c-Fos-IR) following CTb injection in the ventral striatum. These results support a role of 5-HT2AR activation in modulating mPFC and BLA activation during exposure to a novel environment, which may be interrelated. Conversely, 5-HT2AR blockade does not seem to affect the amygdala-striatal projection.
doi_str_mv 10.1016/j.bbr.2017.02.050
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1875141012</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0166432816310531</els_id><sourcerecordid>1875141012</sourcerecordid><originalsourceid>FETCH-LOGICAL-c419t-8089e88f74b8ab791ce37b2fe530907563e0b609590227b54fc591ad055cc5293</originalsourceid><addsrcrecordid>eNp9kU-L1TAUxYMoznP0A7iRLN203qRNm-BqGPwzMOBG1yFNb4c82qQmaZn3KfzK5vFGceUqN5xzD9zfIeQtg5oB6z4c62GINQfW18BrEPCMHJjsedWLVj0nh-Lpqrbh8oq8SukIAC0I9pJcccm7RjbsQH7d-T3MOy7oMw0TTRhDDt55ym9oRItrDpEam91usgueFmUJ4zaXn3-gC47OzHSNOMXgcxltiBkfqfEjNcvpYTSzoR63ohbxn5xxi-cAH3ac86nCxzWkLeJr8mIyc8I3T-81-fH50_fbr9X9ty93tzf3lW2ZypUEqVDKqW8HaYZeMYtNP_AJRQMKetE1CEMHSijgvB9EO1mhmBlBCGsFV801eX_JXWP4uWHKenHJ4jwbj2FLumAUrC2UebGyi9XGkFK5VK_RLSaeNAN97kEfdelBn3vQwHXpoey8e4rfhsLo78Yf8MXw8WLAcuTuMOpkHXpbeBbqWY_B_Sf-N_fHm5E</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1875141012</pqid></control><display><type>article</type><title>Involvement of serotonin 2A receptor activation in modulating medial prefrontal cortex and amygdala neuronal activation during novelty-exposure</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Hervig, Mona El-Sayed ; Jensen, Nadja Cecilie Hvid ; Rasmussen, Nadja Bredo ; Rydbirk, Rasmus ; Olesen, Mikkel Vestergaard ; Hay-Schmidt, Anders ; Pakkenberg, Bente ; Aznar, Susana</creator><creatorcontrib>Hervig, Mona El-Sayed ; Jensen, Nadja Cecilie Hvid ; Rasmussen, Nadja Bredo ; Rydbirk, Rasmus ; Olesen, Mikkel Vestergaard ; Hay-Schmidt, Anders ; Pakkenberg, Bente ; Aznar, Susana</creatorcontrib><description>•Ketanserin blocks novelty-induced neuronal activation in medial prefrontal cortex.•This is accompanied by decreased neuronal activation in the basolateral amygdala.•Ketanserin makes basolateral amygdala more reactive towards the anxiogenic stimulus.•5-HT2A blockade does not affect activation of striatal projecting amygdala neurons. The medial prefrontal cortex (PFC) plays a major role in executive function by exerting a top-down control onto subcortical areas. Novelty-induced frontal cortex activation is 5-HT2A receptor (5-HT2AR) dependent. Here, we further investigated how blockade of 5-HT2ARs in mice exposed to a novel open-field arena affects medial PFC activation and basolateral amygdala (BLA) reactivity. We used c-Fos immunoreactivity (IR) as a marker of neuronal activation and stereological quantification for obtaining the total number of c-Fos-IR neurons as a measure of regional activation. We further examined the impact of 5-HT2AR blockade on the striatal-projecting BLA neurons. Systemic administration of ketanserin (0.5mg/kg) prior to novel open-field exposure resulted in reduced total numbers of c-Fos-IR cells in dorsomedial PFC areas and the BLA. Moreover, there was a positive correlation between the relative time spent in the centre of the open-field and BLA c-Fos-IR in the ketanserin-treated animals. Unilateral medial PFC lesions blocked this effect, ascertaining an involvement of this frontal cortex area. On the other hand, medial PFC lesioning exacerbated the more anxiogenic-like behaviour of the ketanserin-treated animals, upholding its involvement in modulating averseness. Ketanserin did not affect the number of activated striatal-projecting BLA neurons (measured by number of Cholera Toxin b (CTb) retrograde labelled neurons also being c-Fos-IR) following CTb injection in the ventral striatum. These results support a role of 5-HT2AR activation in modulating mPFC and BLA activation during exposure to a novel environment, which may be interrelated. Conversely, 5-HT2AR blockade does not seem to affect the amygdala-striatal projection.</description><identifier>ISSN: 0166-4328</identifier><identifier>EISSN: 1872-7549</identifier><identifier>DOI: 10.1016/j.bbr.2017.02.050</identifier><identifier>PMID: 28263831</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>5-HT2A receptor ; Animals ; Averseness ; Basolateral Nuclear Complex - drug effects ; Basolateral Nuclear Complex - metabolism ; Basolateral Nuclear Complex - physiology ; Behavior, Animal - drug effects ; Behavior, Animal - physiology ; Brain mapping ; Female ; Frontolimbic pathway ; Ketanserin - administration &amp; dosage ; Ketanserin - pharmacology ; Mice ; Mice, Inbred C57BL ; Motor Activity - drug effects ; Motor Activity - physiology ; Neurons - physiology ; Prefrontal Cortex - drug effects ; Prefrontal Cortex - metabolism ; Prefrontal Cortex - physiology ; Receptor, Serotonin, 5-HT2A - metabolism ; Receptor, Serotonin, 5-HT2A - physiology ; Serotonin ; Serotonin 5-HT2 Receptor Antagonists - administration &amp; dosage ; Serotonin 5-HT2 Receptor Antagonists - pharmacology ; Stereology</subject><ispartof>Behavioural brain research, 2017-05, Vol.326, p.1-12</ispartof><rights>2017 Elsevier B.V.</rights><rights>Copyright © 2017 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c419t-8089e88f74b8ab791ce37b2fe530907563e0b609590227b54fc591ad055cc5293</citedby><cites>FETCH-LOGICAL-c419t-8089e88f74b8ab791ce37b2fe530907563e0b609590227b54fc591ad055cc5293</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.bbr.2017.02.050$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28263831$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hervig, Mona El-Sayed</creatorcontrib><creatorcontrib>Jensen, Nadja Cecilie Hvid</creatorcontrib><creatorcontrib>Rasmussen, Nadja Bredo</creatorcontrib><creatorcontrib>Rydbirk, Rasmus</creatorcontrib><creatorcontrib>Olesen, Mikkel Vestergaard</creatorcontrib><creatorcontrib>Hay-Schmidt, Anders</creatorcontrib><creatorcontrib>Pakkenberg, Bente</creatorcontrib><creatorcontrib>Aznar, Susana</creatorcontrib><title>Involvement of serotonin 2A receptor activation in modulating medial prefrontal cortex and amygdala neuronal activation during novelty-exposure</title><title>Behavioural brain research</title><addtitle>Behav Brain Res</addtitle><description>•Ketanserin blocks novelty-induced neuronal activation in medial prefrontal cortex.•This is accompanied by decreased neuronal activation in the basolateral amygdala.•Ketanserin makes basolateral amygdala more reactive towards the anxiogenic stimulus.•5-HT2A blockade does not affect activation of striatal projecting amygdala neurons. The medial prefrontal cortex (PFC) plays a major role in executive function by exerting a top-down control onto subcortical areas. Novelty-induced frontal cortex activation is 5-HT2A receptor (5-HT2AR) dependent. Here, we further investigated how blockade of 5-HT2ARs in mice exposed to a novel open-field arena affects medial PFC activation and basolateral amygdala (BLA) reactivity. We used c-Fos immunoreactivity (IR) as a marker of neuronal activation and stereological quantification for obtaining the total number of c-Fos-IR neurons as a measure of regional activation. We further examined the impact of 5-HT2AR blockade on the striatal-projecting BLA neurons. Systemic administration of ketanserin (0.5mg/kg) prior to novel open-field exposure resulted in reduced total numbers of c-Fos-IR cells in dorsomedial PFC areas and the BLA. Moreover, there was a positive correlation between the relative time spent in the centre of the open-field and BLA c-Fos-IR in the ketanserin-treated animals. Unilateral medial PFC lesions blocked this effect, ascertaining an involvement of this frontal cortex area. On the other hand, medial PFC lesioning exacerbated the more anxiogenic-like behaviour of the ketanserin-treated animals, upholding its involvement in modulating averseness. Ketanserin did not affect the number of activated striatal-projecting BLA neurons (measured by number of Cholera Toxin b (CTb) retrograde labelled neurons also being c-Fos-IR) following CTb injection in the ventral striatum. These results support a role of 5-HT2AR activation in modulating mPFC and BLA activation during exposure to a novel environment, which may be interrelated. Conversely, 5-HT2AR blockade does not seem to affect the amygdala-striatal projection.</description><subject>5-HT2A receptor</subject><subject>Animals</subject><subject>Averseness</subject><subject>Basolateral Nuclear Complex - drug effects</subject><subject>Basolateral Nuclear Complex - metabolism</subject><subject>Basolateral Nuclear Complex - physiology</subject><subject>Behavior, Animal - drug effects</subject><subject>Behavior, Animal - physiology</subject><subject>Brain mapping</subject><subject>Female</subject><subject>Frontolimbic pathway</subject><subject>Ketanserin - administration &amp; dosage</subject><subject>Ketanserin - pharmacology</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Motor Activity - drug effects</subject><subject>Motor Activity - physiology</subject><subject>Neurons - physiology</subject><subject>Prefrontal Cortex - drug effects</subject><subject>Prefrontal Cortex - metabolism</subject><subject>Prefrontal Cortex - physiology</subject><subject>Receptor, Serotonin, 5-HT2A - metabolism</subject><subject>Receptor, Serotonin, 5-HT2A - physiology</subject><subject>Serotonin</subject><subject>Serotonin 5-HT2 Receptor Antagonists - administration &amp; dosage</subject><subject>Serotonin 5-HT2 Receptor Antagonists - pharmacology</subject><subject>Stereology</subject><issn>0166-4328</issn><issn>1872-7549</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU-L1TAUxYMoznP0A7iRLN203qRNm-BqGPwzMOBG1yFNb4c82qQmaZn3KfzK5vFGceUqN5xzD9zfIeQtg5oB6z4c62GINQfW18BrEPCMHJjsedWLVj0nh-Lpqrbh8oq8SukIAC0I9pJcccm7RjbsQH7d-T3MOy7oMw0TTRhDDt55ym9oRItrDpEam91usgueFmUJ4zaXn3-gC47OzHSNOMXgcxltiBkfqfEjNcvpYTSzoR63ohbxn5xxi-cAH3ac86nCxzWkLeJr8mIyc8I3T-81-fH50_fbr9X9ty93tzf3lW2ZypUEqVDKqW8HaYZeMYtNP_AJRQMKetE1CEMHSijgvB9EO1mhmBlBCGsFV801eX_JXWP4uWHKenHJ4jwbj2FLumAUrC2UebGyi9XGkFK5VK_RLSaeNAN97kEfdelBn3vQwHXpoey8e4rfhsLo78Yf8MXw8WLAcuTuMOpkHXpbeBbqWY_B_Sf-N_fHm5E</recordid><startdate>20170530</startdate><enddate>20170530</enddate><creator>Hervig, Mona El-Sayed</creator><creator>Jensen, Nadja Cecilie Hvid</creator><creator>Rasmussen, Nadja Bredo</creator><creator>Rydbirk, Rasmus</creator><creator>Olesen, Mikkel Vestergaard</creator><creator>Hay-Schmidt, Anders</creator><creator>Pakkenberg, Bente</creator><creator>Aznar, Susana</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20170530</creationdate><title>Involvement of serotonin 2A receptor activation in modulating medial prefrontal cortex and amygdala neuronal activation during novelty-exposure</title><author>Hervig, Mona El-Sayed ; Jensen, Nadja Cecilie Hvid ; Rasmussen, Nadja Bredo ; Rydbirk, Rasmus ; Olesen, Mikkel Vestergaard ; Hay-Schmidt, Anders ; Pakkenberg, Bente ; Aznar, Susana</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c419t-8089e88f74b8ab791ce37b2fe530907563e0b609590227b54fc591ad055cc5293</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>5-HT2A receptor</topic><topic>Animals</topic><topic>Averseness</topic><topic>Basolateral Nuclear Complex - drug effects</topic><topic>Basolateral Nuclear Complex - metabolism</topic><topic>Basolateral Nuclear Complex - physiology</topic><topic>Behavior, Animal - drug effects</topic><topic>Behavior, Animal - physiology</topic><topic>Brain mapping</topic><topic>Female</topic><topic>Frontolimbic pathway</topic><topic>Ketanserin - administration &amp; dosage</topic><topic>Ketanserin - pharmacology</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Motor Activity - drug effects</topic><topic>Motor Activity - physiology</topic><topic>Neurons - physiology</topic><topic>Prefrontal Cortex - drug effects</topic><topic>Prefrontal Cortex - metabolism</topic><topic>Prefrontal Cortex - physiology</topic><topic>Receptor, Serotonin, 5-HT2A - metabolism</topic><topic>Receptor, Serotonin, 5-HT2A - physiology</topic><topic>Serotonin</topic><topic>Serotonin 5-HT2 Receptor Antagonists - administration &amp; dosage</topic><topic>Serotonin 5-HT2 Receptor Antagonists - pharmacology</topic><topic>Stereology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hervig, Mona El-Sayed</creatorcontrib><creatorcontrib>Jensen, Nadja Cecilie Hvid</creatorcontrib><creatorcontrib>Rasmussen, Nadja Bredo</creatorcontrib><creatorcontrib>Rydbirk, Rasmus</creatorcontrib><creatorcontrib>Olesen, Mikkel Vestergaard</creatorcontrib><creatorcontrib>Hay-Schmidt, Anders</creatorcontrib><creatorcontrib>Pakkenberg, Bente</creatorcontrib><creatorcontrib>Aznar, Susana</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Behavioural brain research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hervig, Mona El-Sayed</au><au>Jensen, Nadja Cecilie Hvid</au><au>Rasmussen, Nadja Bredo</au><au>Rydbirk, Rasmus</au><au>Olesen, Mikkel Vestergaard</au><au>Hay-Schmidt, Anders</au><au>Pakkenberg, Bente</au><au>Aznar, Susana</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Involvement of serotonin 2A receptor activation in modulating medial prefrontal cortex and amygdala neuronal activation during novelty-exposure</atitle><jtitle>Behavioural brain research</jtitle><addtitle>Behav Brain Res</addtitle><date>2017-05-30</date><risdate>2017</risdate><volume>326</volume><spage>1</spage><epage>12</epage><pages>1-12</pages><issn>0166-4328</issn><eissn>1872-7549</eissn><abstract>•Ketanserin blocks novelty-induced neuronal activation in medial prefrontal cortex.•This is accompanied by decreased neuronal activation in the basolateral amygdala.•Ketanserin makes basolateral amygdala more reactive towards the anxiogenic stimulus.•5-HT2A blockade does not affect activation of striatal projecting amygdala neurons. The medial prefrontal cortex (PFC) plays a major role in executive function by exerting a top-down control onto subcortical areas. Novelty-induced frontal cortex activation is 5-HT2A receptor (5-HT2AR) dependent. Here, we further investigated how blockade of 5-HT2ARs in mice exposed to a novel open-field arena affects medial PFC activation and basolateral amygdala (BLA) reactivity. We used c-Fos immunoreactivity (IR) as a marker of neuronal activation and stereological quantification for obtaining the total number of c-Fos-IR neurons as a measure of regional activation. We further examined the impact of 5-HT2AR blockade on the striatal-projecting BLA neurons. Systemic administration of ketanserin (0.5mg/kg) prior to novel open-field exposure resulted in reduced total numbers of c-Fos-IR cells in dorsomedial PFC areas and the BLA. Moreover, there was a positive correlation between the relative time spent in the centre of the open-field and BLA c-Fos-IR in the ketanserin-treated animals. Unilateral medial PFC lesions blocked this effect, ascertaining an involvement of this frontal cortex area. On the other hand, medial PFC lesioning exacerbated the more anxiogenic-like behaviour of the ketanserin-treated animals, upholding its involvement in modulating averseness. Ketanserin did not affect the number of activated striatal-projecting BLA neurons (measured by number of Cholera Toxin b (CTb) retrograde labelled neurons also being c-Fos-IR) following CTb injection in the ventral striatum. These results support a role of 5-HT2AR activation in modulating mPFC and BLA activation during exposure to a novel environment, which may be interrelated. Conversely, 5-HT2AR blockade does not seem to affect the amygdala-striatal projection.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>28263831</pmid><doi>10.1016/j.bbr.2017.02.050</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0166-4328
ispartof Behavioural brain research, 2017-05, Vol.326, p.1-12
issn 0166-4328
1872-7549
language eng
recordid cdi_proquest_miscellaneous_1875141012
source MEDLINE; Elsevier ScienceDirect Journals
subjects 5-HT2A receptor
Animals
Averseness
Basolateral Nuclear Complex - drug effects
Basolateral Nuclear Complex - metabolism
Basolateral Nuclear Complex - physiology
Behavior, Animal - drug effects
Behavior, Animal - physiology
Brain mapping
Female
Frontolimbic pathway
Ketanserin - administration & dosage
Ketanserin - pharmacology
Mice
Mice, Inbred C57BL
Motor Activity - drug effects
Motor Activity - physiology
Neurons - physiology
Prefrontal Cortex - drug effects
Prefrontal Cortex - metabolism
Prefrontal Cortex - physiology
Receptor, Serotonin, 5-HT2A - metabolism
Receptor, Serotonin, 5-HT2A - physiology
Serotonin
Serotonin 5-HT2 Receptor Antagonists - administration & dosage
Serotonin 5-HT2 Receptor Antagonists - pharmacology
Stereology
title Involvement of serotonin 2A receptor activation in modulating medial prefrontal cortex and amygdala neuronal activation during novelty-exposure
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T00%3A00%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Involvement%20of%20serotonin%202A%20receptor%20activation%20in%20modulating%20medial%20prefrontal%20cortex%20and%20amygdala%20neuronal%20activation%20during%20novelty-exposure&rft.jtitle=Behavioural%20brain%20research&rft.au=Hervig,%20Mona%20El-Sayed&rft.date=2017-05-30&rft.volume=326&rft.spage=1&rft.epage=12&rft.pages=1-12&rft.issn=0166-4328&rft.eissn=1872-7549&rft_id=info:doi/10.1016/j.bbr.2017.02.050&rft_dat=%3Cproquest_cross%3E1875141012%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1875141012&rft_id=info:pmid/28263831&rft_els_id=S0166432816310531&rfr_iscdi=true